articles about swine vaccine - Pig333.com

Day one Mycoplasma hyopneumoniae vaccination now possible with RespiSure-ONE®

[Company news]

Pork producers in US can now vaccinate for mycoplasmal pneumonia at day one.

Intervet/Schering-Plough animal health demonstrates efficacy of simultaneous use of circovirus and mycoplasma vaccines in swine

Simultaneous (mixed) use of existing swine vaccines against porcine circovirus 2 (PCV2) and Mycoplasma hyopneumoniae (M. hyo) from Intervet/Schering-Plough Animal Health in swine are as efficacious and safe as separate use of these vaccines.

IDRI And Merial Enter Into Research Collaboration

[Company news]

Global animal health company Merial Ltd. and non-profit biotechnology organization the Infectious Disease Research Institute (IDRI) today announce they have agreed to cooperate regarding the research and development of certain vaccines for animals.

Biolex and Merial Broaden Collaboration

[Company news]

Biolex Therapeutics, Inc and Merial Ltd today announced that they have entered into a new, broad-ranging research and development collaboration to produce innovative veterinary vaccines.

First PCV-2 / Mycoplasma hyopneumoniae vaccine combination registered in the European Union

[Company news]

The EU Commission has approved the simultaneous use of the pig vaccines Ingelvac CircoFLEX^® and Ingelvac MycoFLEX^® in the European Union. Boehringer Ingelheim will market this unique vaccine concept under the name FLEXcombo^®.

Boehringer Ingelheim launches PCV2 vaccine in Russia

[Company news]

With the launch of Ingelvac CircoFLEX® by Boehringer Ingelheim on the Russian market, pig producers in Russia now have access to the world’s market leading vaccine against porcine Circovirus type 2 (PCV2).

Intervet/Schering-Plough Animal Health receives positive opinion in europe for simultaneous use of Porcilis® PRRS and Porcilis® M hyo vaccines in piglets

[Company news]

Intervet/Schering-Plough Animal Health, announces today that the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency (EMA) concluded the referral procedure for PORCILIS® PRRS and for PORCILIS® M Hyo on simultaneous administration of these products in piglets